Zanidatamab plus palbociclib and fulvestrant in previously treated patients with hormone receptor-positive, HER2-positive metastatic breast cancer: primary results from a two-part, multicentre, single-arm, phase 2a study., PMID:40339592
Primary antifungal prophylaxis in hematological malignancies. Updated clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL)., PMID:40200079
The Impact of Age and Disease Entity on Small Airway Dysfunction in Obstructive Airway Diseases., PMID:40166685
Antisynthetase syndrome with anti-glycyl tRNA synthetase antibodies in a patient with axial spondyloarthritis treated with tumor necrosis factor-α inhibitors., PMID:39932245
Neoadjuvant nivolumab and chemotherapy in early estrogen receptor-positive breast cancer: a randomized phase 3 trial., PMID:39838118
Phase I study of BMS-986299, an NLRP3 agonist, as monotherapy and in combination with nivolumab and ipilimumab in patients with advanced solid tumors., PMID:39824531
A Preclinical Immunogenicity Study of the Recombinant Human Papillomavirus Nine-Valent Virus-like Particle Vaccine., PMID:39772018
Longitudinal Study of SARS-CoV-2 Vaccinations and Infections in Patients with Gastrointestinal Cancer: Stabilizing Immune Responses and Neutralizing Emerging Variants with Variant-Adapted Antigen Exposures., PMID:39769379
Mechanisms of reduced sensitization by extensive hydrolysis of milk protein concentrate: Impact on the immune response of Th1/Th2 and Treg/Th17 cells in mice., PMID:39662801
Immunoinformatics design of a multi-epitope vaccine for Chlamydia trachomatis major outer membrane proteins., PMID:39623035
Characterization of anti-EBNA-1 antibodies and exploration of their molecular mimicry potential in an EBV-infected Sjögren's syndrome patient., PMID:39427375
Sabatolimab in combination with spartalizumab in patients with non-small cell lung cancer or melanoma who received prior treatment with anti-PD-1/PD-L1 therapy: a phase 2 multicentre study., PMID:39209782
Simulation-driven design of stabilized SARS-CoV-2 spike S2 immunogens., PMID:39191724
Structural study of a light chain mispaired bispecific predicts mechanism of downstream separation., PMID:38972252
"Positioning of tucatinib in the new clinical scenario of HER2-positive metastatic breast cancer: An Italian and Spanish consensus paper"., PMID:38772190
Trastuzumab deruxtecan in patients with solid tumours harbouring specific activating HER2 mutations (DESTINY-PanTumor01): an international, phase 2 study., PMID:38710187
An RNA-hydrolyzing recombinant minibody prevents both influenza A virus and coronavirus in co-infection models., PMID:38605110
Longitudinal analysis of external quality assessment of immunoassay-based steroid hormone measurement indicates potential for improvement in standardization., PMID:38357630
The coincidence of climate extremes with sensitive crop growth phases: Projected impact on sustainable crop water use and crop yield in the IGB river basins., PMID:38181960
Trastuzumab deruxtecan in previously treated patients with HER2-positive metastatic breast cancer: updated survival results from a phase II trial (DESTINY-Breast01)., PMID:38092229
Progressive clinical effects of the combination omalizumab and HDM - allergen immunotherapy in asthma., PMID:38064236
[Diagnostic value of anti-Sa antibody and anti-carbamylated protein antibody for rheumatoid arthritis]., PMID:37752054
Neoadjuvant nivolumab + palbociclib + anastrozole for oestrogen receptor-positive/human epidermal growth factor receptor 2-negative primary breast cancer: Results from CheckMate 7A8., PMID:37741273
Neratinib + fulvestrant + trastuzumab for HR-positive, HER2-negative, HER2-mutant metastatic breast cancer: outcomes and biomarker analysis from the SUMMIT trial., PMID:37597578
Identification of potential classes of glycoligands mediating dynamic endothelial adhesion of human tumor cells., PMID:37486674
Clinical and pathogenic significance of S100A4 overexpression in systemic sclerosis., PMID:37414521
Chronic SIRT1 supplementation in diabetic mice improves endothelial function by suppressing oxidative stress., PMID:37401647
Bioanalytical Assays for Pharmacokinetic and Biodistribution Study of Antibody-Drug Conjugates., PMID:37290939
Real-life effects of benralizumab on airway oscillometry in severe eosinophilic asthma., PMID:37208039
Orally Bioavailable Macrocyclic Peptide That Inhibits Binding of PCSK9 to the Low Density Lipoprotein Receptor., PMID:37125593
The change of paradigm in the treatment of HER2-positive breast cancer with the development of new generation antibody-drug conjugates., PMID:37065870
Sialofucosylation Enables Platelet Binding to Myeloma Cells via P-Selectin and Suppresses NK Cell-Mediated Cytotoxicity., PMID:37046814
[A Case of Locally Advanced Breast Cancer That Responded to Paclitaxel plus Bevacizumab and Underwent Radical Surgery]., PMID:36733163
Systemic sclerosis and primary biliary cholangitis share an antibody population with identical specificity., PMID:36715304
Uveitis in psoriatic arthritis: study of 406 patients in a single university center and literature review., PMID:36635002
Systemic Therapy for HER2-Positive Metastatic Breast Cancer: Current and Future Trends., PMID:36612047
Discovery of an agonistic Siglec-6 antibody that inhibits and reduces human mast cells., PMID:36369358
Characterization of high Arabinoxylan oat lines identified from a mutagenized oat population., PMID:36323030
Immunoglobulins genes in Neoceratodus forsteri and Protopterus annectens explain the origin of the immunoglobulins of the animals that passed ashore., PMID:36308969
Detection of a weaker subgroup of A in ABO blood group system., PMID:36199401
A naturally arising broad and potent CD4-binding site antibody with low somatic mutation., PMID:35960796
Optimizing Epitope Conformational Ensembles Using α-Synuclein Cyclic Peptide "Glycindel" Scaffolds: A Customized Immunogen Method for Generating Oligomer-Selective Antibodies for Parkinson's Disease., PMID:35840132
Detection of Serum-Specific IgE by Fluoro-Enzyme Immunoassay for Diagnosing Type I Hypersensitivity Reactions to Penicillins., PMID:35805992
A first-in-human phase 1/2 study of FGF401 and combination of FGF401 with spartalizumab in patients with hepatocellular carcinoma or biomarker-selected solid tumors., PMID:35655320
A Therapeutically Active Minibody Exhibits an Antiviral Activity in Oseltamivir-Resistant Influenza-Infected Mice via Direct Hydrolysis of Viral RNAs., PMID:35632846
First Report of Bacterial Leaf Scald of Plum Caused by Xylella fastidiosa in Texas., PMID:35486598
Neutralization of GDF15 Prevents Anorexia and Weight Loss in the Monocrotaline-Induced Cardiac Cachexia Rat Model., PMID:35406637
SARS-CoV-2 Neutralizing Monoclonal Antibodies for the Treatment of COVID-19 in Kidney Transplant Recipients., PMID:35368573
Updated efficacy and safety of KEYNOTE-224: a phase II study of pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib., PMID:35364421
The Inhibitory Receptor Siglec-8 Interacts With FcεRI and Globally Inhibits Intracellular Signaling in Primary Mast Cells Upon Activation., PMID:35154156
For research use only. Not for human or drug use.
